• Skip to primary navigation
  • Skip to main content
SRI logo
  • About
    • Press room
    • Our history
  • Expertise
    • Advanced imaging systems
    • Artificial intelligence
    • Biomedical R&D services
    • Biomedical sciences
    • Computer vision
    • Cyber & formal methods
    • Education and learning
    • Innovation strategy and policy
    • National security
    • Ocean & space
    • Quantum
    • Robotics, sensors & devices
    • Speech & natural language
    • Video test & measurement
  • Ventures
  • NSIC
  • Careers
  • Contact
  • 日本支社
Search
Close
Bios September 8, 2021

Shravan K Mutyam

Research Associate, Formulation R&D, Applied Research

Shravan K Mutyam researches pharmaceutical excipients and their functionalities to develop pre-clinical and clinical pharmaceutical formulations. He is involved in formulation development efforts of several drug candidates including NCEs for animal toxicology, PK-PD and bioavailability studies – specifically molecules with poor solubility and permeability by developing enabling formulations.

Mutyam designs and assists in development of preclinical formulations from lab scale to Phase I clinical formulations. He has worked with formulation development of diverse dosage forms including oral solid dosage forms (tablets and capsules), immediate release/modified release dosage forms, lipid-based formulations, maltiparticulate bead capsule formulations, solutions, suspensions, microspheres, powder in bottle, vaccines, emulsions, spray dried dispersions (SDD), self-emulsifying drug delivery systems (SEDDS), parenteral and transdermal formulations.

Mutyam received his M.S. in Chemistry from Lamar University, Beaumont, Texas and holds a certificate in Project Management (Life Sciences and Drug Development) from University of California, Berkeley Ext. He has a bachelor’s degree in pharmaceutical sciences (bachelor of pharmacy) from Osmania University, Hyderabad, India and a diploma in pharmacy from Govt. Polytechnic, Hyderabad, India.

Recent publications

more +
  • Formulation Approaches to Improving the Delivery of an Antiviral Drug with Activity against Seasonal Flu

    The main objective of the present study was to develop formulations of noscapine hydrochloride hydrate with enhanced solubility and bioavailability using co-solvent- and cyclodextrin-based approaches.

  • Tablet formulation of an active pharmaceutical ingredient with a sticking and filming problem: direct compression and dry granulation evaluations

    Direct compression and dry granulation tableting techniques were evaluated using factorial experimental design.

  • Permeability Enhancing Lipid-Based Co-Solvent and SEDDS Formulations of SQ641, an Antimycobacterial Agent

    The objective of this study was to develop an oral preclinical liquid formulation of SQ641 and to determine the permeability across rat intestinal tissue by Ussing chamber.

How can we help?

Once you hit send…

We’ll match your inquiry to the person who can best help you.

Expect a response within 48 hours.

Career call to action image

Make your own mark.

Search jobs

Our work

Case studies

Publications

Timeline of innovation

Areas of expertise

Institute

Leadership

Press room

Media inquiries

Compliance

Careers

Job listings

Contact

SRI Ventures

Our locations

Headquarters

333 Ravenswood Ave
Menlo Park, CA 94025 USA

+1 (650) 859-2000

Subscribe to our newsletter


日本支社
SRI International
  • Contact us
  • Privacy Policy
  • Cookies
  • DMCA
  • Copyright © 2023 SRI International
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}